Cowa, LLC Amgen Inc Transaction History

Cowa, LLC

$187 Billion
Q2 2024

A detailed history of Cowa, LLC transactions in Amgen Inc stock. As of the latest transaction made, Cowa, LLC holds 3,228 shares of AMGN stock, worth $1.04 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

3,228

Previous 3,439 6.14%

Holding current value

$1.04 Million

Previous $978 Million 3.16%

% of portfolio

0.54%

Previous 0.58%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$262.75 - $319.31 $55,440 - $67,374	-211 Reduced 6.14%	3,228 $1.01 Billion
Q1 2024 May 07, 2024	BUY	$268.87 - $324.56 $12,905 - $15,578	48 Added 1.42%	3,439 $978 Million
Q4 2023 Jan 16, 2024	BUY	$255.7 - $288.46 $3,068 - $3,461	12 Added 0.36%	3,391 $977 Million
Q3 2023 Oct 30, 2023	BUY	$218.65 - $271.46 $218 - $271	1 Added 0.03%	3,379 $908 Million
Q2 2023 Jul 25, 2023	BUY	$214.27 - $253.37 $80,351 - $95,013	375 Added 12.49%	3,378 $750 Million
Q1 2023 May 04, 2023	SELL	$225.79 - $275.2 $16,934 - $20,640	-75 Reduced 2.44%	3,003 $725,000
Q4 2022 Jan 27, 2023	BUY	$229.03 - $291.01 $25,422 - $32,302	111 Added 3.74%	3,078 $0
Q3 2022 Nov 04, 2022	BUY	$224.46 - $253.15 $47,585 - $53,667	212 Added 7.7%	2,967 $669,000
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $103,819 - $115,533	450 Added 19.52%	2,755 $670,000
Q1 2022 May 18, 2022	SELL	$219.27 - $242.57 $50 Million - $55.4 Million	-228,207 Reduced 99.0%	2,305 $557,000
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $50.1 Million - $55.4 Million	228,517 Added 11454.49%	230,512 $557,000
Q4 2021 Feb 04, 2022	BUY	$198.88 - $227.6 $396,765 - $454,062	1,995 New	1,995 $449,000

Others Institutions Holding AMGN

# of Institutions

3,055

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $172B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cowa, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cowa, LLC with notifications on news.

Account